SCHEMBL97988

SCHEMBL97988

[143Pr]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29598459 0.71
Methane SCHEMBL23088734 0.00
Hydrogen Sulfide SCHEMBL23805181 0.00
SCHEMBL23528133 0.00
SCHEMBL23358113 0.00
SCHEMBL23462252 0.00
SCHEMBL25435013 0.00
SCHEMBL23462141 0.00
Potassium Ion SCHEMBL23462035 0.00 CA4 (0.50)
SCHEMBL23462036 0.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 964 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260083866-A1 COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2026-03-26 US claimed
WO-2024243545-A1 COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-11-28 WO claimed
EP-3999175-A2 STRONTIUM SEALED SOURCE QSA Global, Inc. (US) 2022-05-25 EP claimed
CN-114531917-A Strontium sealed source QSA全球有限公司 2022-05-24 CN claimed
US-11318326-B2 Strontium sealed source QSA GLOBAL INC. (US) 2022-05-03 US claimed
WO-2021011175-A2 STRONTIUM SEALED SOURCE QSA GLOBAL, INC. (US) 2021-01-21 WO claimed
US-10787499-B2 EpCAM targeted polypeptides, conjugates thereof, and methods of use thereof REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2020-09-29 US claimed
US-20190336791-A1 STRONTIUM SEALED SOURCE QSA GLOBAL INC. 2019-11-07 US claimed
US-10166304-B2 Antibody fragments for detecting cancer and methods of use REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2019-01-01 US claimed
US-20180251524-A1 EpCAM TARGETED POLYPEPTIDES, CONJUGATES THEREOF, AND METHODS OF USE THEREOF REGENTS OF THE UNIVERSITY OF MINNESOTA 2018-09-06 US claimed
US-5525338-A Detection and therapy of lesions with biotin/avidin conjugates IMMUNOMEDICS, INC. (US) 1996-06-11 US claimed
EP-0700304-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN-METAL CHELATING PROTEIN CONJUGATES Immunomedics, Inc. (US) 1996-03-13 EP claimed
EP-0695194-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN POLYMER CONJUGATES Immunomedics, Inc. (US) 1996-02-07 EP claimed
US-5482698-A Detection and therapy of lesions with biotin/avidin polymer conjugates IMMUNOMEDICS, INC. (US) 1996-01-09 US claimed
EP-0656115-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN CONJUGATES Immunomedics, Inc. (US) 1995-06-07 EP claimed
EP-0637933-A1 METHOD AND KIT FOR IMAGING AND TREATING ORGANS AND TISSUES Immunomedics, Inc. (US) 1995-02-15 EP claimed
WO-1994026297-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN-METAL CHELATING PROTEIN CONJUGATES IMMUNOMEDICS, INC. (US) 1994-11-24 WO claimed
WO-1994023759-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN POLYMER CONJUGATES IMMUNOMEDICS, INC. (US) 1994-10-27 WO claimed
WO-1994004702-A2 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN CONJUGATES IMMUNOMEDICS, INC. (US) 1994-03-03 WO claimed
WO-1993019668-A1 METHOD AND KIT FOR IMAGING AND TREATING ORGANS AND TISSUES IMMUNOMEDICS, INC. (US) 1993-10-14 WO claimed